Phreesia (NYSE:PHR) Stock Price Up 6%

Phreesia, Inc. (NYSE:PHR)’s stock price rose 6% during mid-day trading on Friday . The stock traded as high as $22.06 and last traded at $21.84. Approximately 152,874 shares traded hands during mid-day trading, a decline of 69% from the average daily volume of 490,468 shares. The stock had previously closed at $20.61.

Wall Street Analyst Weigh In

PHR has been the topic of several recent research reports. JMP Securities restated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research report on Friday, May 31st. Stephens reiterated an “overweight” rating and issued a $28.00 target price on shares of Phreesia in a research note on Friday, May 31st. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Friday, May 31st. Canaccord Genuity Group dropped their target price on Phreesia from $37.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 31st. Finally, KeyCorp dropped their target price on Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.54.

Phreesia Stock Performance

The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of -10.05 and a beta of 0.93. The stock’s 50 day moving average price is $21.09 and its 200 day moving average price is $23.06.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.16. The business had revenue of $101.20 million during the quarter, compared to the consensus estimate of $100.94 million. Phreesia had a negative net margin of 31.87% and a negative return on equity of 46.89%. The company’s revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.70) earnings per share. Analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 1,238 shares of the company’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $28,300.68. Following the sale, the general counsel now owns 135,621 shares in the company, valued at approximately $3,100,296.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, General Counsel Allison C. Hoffman sold 1,238 shares of the stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $22.86, for a total transaction of $28,300.68. Following the completion of the transaction, the general counsel now directly owns 135,621 shares of the company’s stock, valued at approximately $3,100,296.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Chaim Indig sold 3,392 shares of the stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $22.86, for a total transaction of $77,541.12. Following the transaction, the chief executive officer now directly owns 1,222,005 shares of the company’s stock, valued at $27,935,034.30. The disclosure for this sale can be found here. Insiders have sold a total of 9,980 shares of company stock worth $226,944 over the last quarter. Company insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Institutional investors and hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC lifted its position in Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares during the period. Russell Investments Group Ltd. lifted its position in Phreesia by 5,462.3% during the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock valued at $89,000 after acquiring an additional 3,769 shares during the period. EntryPoint Capital LLC purchased a new position in Phreesia during the 1st quarter valued at about $169,000. Quadrature Capital Ltd purchased a new position in Phreesia during the 1st quarter valued at about $202,000. Finally, ProShare Advisors LLC lifted its position in Phreesia by 8.6% during the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after acquiring an additional 751 shares during the period. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.